PMID- 19794977 OWN - NLM STAT- MEDLINE DCOM- 20100127 LR - 20211020 IS - 1598-6357 (Electronic) IS - 1011-8934 (Print) IS - 1011-8934 (Linking) VI - 24 IP - 5 DP - 2009 Oct TI - Short- and long-term results of triple valve surgery: a single center experience. PG - 818-23 LID - 10.3346/jkms.2009.24.5.818 [doi] AB - Triple valve surgery is usually complex and carries a reported operative mortality of 13% and 10-yr survival of 61%. We examined surgical results based on our hospital's experience. A total of 160 consecutive patients underwent triple valve surgery from 1990 to 2006. The most common aortic and mitral valve disease was rheumatic disease (82%). The most common tricuspid valve disease was functional regurgitation (80%). Seventy-four percent of the patients were in New York Heart Association (NYHA) class III and IV. Univariate and multivariable analyses were performed to identify predictors of early and late survival. Operative mortality was 6.9% (n=11). Univariate factors associated with mortality included old age, preoperative renal failure, postoperative renal failure, pulmonary complications, and stroke. Of them, postoperative renal failure and stroke were associated with mortality on multivariable analysis. Otherwise, neither tricuspid valve replacement nor reoperation were statistically associated with late mortality. Survival at 5 and 10 yr was 87% and 84%, respectively. Ninety-two percent of the patients were in NYHA class I and II at their most recent follow-up. Ten-year freedom from prosthetic valve endocarditis was 97%; from anticoagulation-related hemorrhage, 82%; from thromboembolism, 89%; and from reoperation, 84%. Postoperative renal failure and stroke were significantly related with operative mortality. Triple valve surgery, regardless of reoperation and tricuspid valve replacement, results in acceptable long-term survival. FAU - Shinn, Sung Ho AU - Shinn SH AD - Department of Thoracic and Cardiovascular Surgery, Hanyang University Guri Hospital, College of Medicine, University of Hanyang, Guri, Korea. FAU - Oh, Sam-Sae AU - Oh SS FAU - Na, Chan Young AU - Na CY FAU - Lee, Chang-Ha AU - Lee CH FAU - Lim, Hong-Gook AU - Lim HG FAU - Kim, Jae Hyun AU - Kim JH FAU - Yie, Kil Soo AU - Yie KS FAU - Baek, Man Jong AU - Baek MJ FAU - Song, Dong Seop AU - Song DS LA - eng PT - Journal Article DEP - 20090924 PL - Korea (South) TA - J Korean Med Sci JT - Journal of Korean medical science JID - 8703518 RN - 0 (Anticoagulants) SB - IM MH - Adult MH - Aged MH - Anticoagulants/adverse effects/therapeutic use MH - Aortic Valve/*surgery MH - Female MH - Heart Valve Diseases/complications/mortality/*surgery MH - Heart Valve Prosthesis Implantation/*methods MH - Hemorrhage/chemically induced/epidemiology MH - Humans MH - Intraoperative Complications/mortality MH - Male MH - Middle Aged MH - Mitral Valve/*surgery MH - Postoperative Complications/mortality MH - Renal Insufficiency/etiology MH - Reoperation MH - Risk Factors MH - Severity of Illness Index MH - Stroke/etiology MH - Survival Analysis MH - Thromboembolism/epidemiology MH - Tricuspid Valve/*surgery PMC - PMC2752762 OTO - NOTNLM OT - Renal Failure OT - Stroke OT - Triple valve surgery EDAT- 2009/10/02 06:00 MHDA- 2010/01/28 06:00 PMCR- 2009/10/01 CRDT- 2009/10/02 06:00 PHST- 2008/08/03 00:00 [received] PHST- 2008/11/28 00:00 [accepted] PHST- 2009/10/02 06:00 [entrez] PHST- 2009/10/02 06:00 [pubmed] PHST- 2010/01/28 06:00 [medline] PHST- 2009/10/01 00:00 [pmc-release] AID - 10.3346/jkms.2009.24.5.818 [doi] PST - ppublish SO - J Korean Med Sci. 2009 Oct;24(5):818-23. doi: 10.3346/jkms.2009.24.5.818. Epub 2009 Sep 24.